Creative Planning Abbott Laboratories Call Options Transaction History

Creative Planning

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $79,814 - $97,328	-700 Reduced 58.33%	500 $9,000
Q1 2021 Apr 30, 2021	SELL	$108.84 - $128.23 $21,768 - $25,645	-200 Reduced 14.29%	1,200 $19,000
Q4 2020 Jan 29, 2021	SELL	$105.0 - $114.42 $430,500 - $469,122	-4,100 Reduced 74.55%	1,400 $14,000
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $458,200 - $556,450	5,000 Added 1000.0%	5,500 $21,000
Q2 2020 Jul 23, 2020	SELL	$76.57 - $98.0 $7,656 - $9,800	-100 Reduced 16.67%	500 $1,000
Q1 2020 May 05, 2020	BUY	$62.82 - $91.86 $31,410 - $45,930	500 Added 500.0%	600 $1,000
Q1 2018 Apr 18, 2018	BUY	$56.27 - $63.62 $5,627 - $6,362	100 New	100 $2,000

3,187

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.